… aneurysms to find new targets for diagnosis and treatment. To better understand aortic
aneurysm… Type I lesions extend from the ascending aorta to the abdominal aorta, and the lining of …

… Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health …
need for therapy. This disease is featured by a progressive dilation of the abdominal aorta, …

… Up to now, there is still controversy on the choice of treatment method of AAA. Even so,
the mechanisms of AAA progression are poorly defined, making targeting new therapies …

… Research over the past decade has identified novel contributors to aneurysm … abdominal
aortic aneurysm growth and efforts underway to develop effective pharmacological treatments …

… MMP2 and MMP9 mRNA levels were assessed by RT-PCR at 0, 2, 4, and 6 h following the
treatment (F) and normalized to the mean level before the actinomycin treatment (0 h), which …

… Atherosclerosis, although more frequently implicated in descending thoracic and abdominal
aortic aneurysms, might also be an etiologic factor for TAAAs and VAAs [13,14], while …

… The cardiovascular field is still searching for a treatment for abdominal aortic aneurysms (AAA).
This inflammatory disease often goes undiagnosed until a late stage and associated …

… , understanding of novel immune mediated mechanisms regulating AAA development and
factors driving pathogenic immune cell activation will pave the road for novel therapeutics and …

… and therapies to limit AAA growth. Genome-wide association studies have identified novel
drug targets… Mendelian randomization analyses suggest that treatments to reduce low-density …

… We also highlighted the novel management methods that … thoracic aortic aneurysm (TAA),
abdominal aortic aneurysms (… to aortic aneurysms has a dynamic landscape of treatment …